Impact of dipeptidyl-peptidase 4 inhibitors on cardiovascular diseases.

Xie, Weijia

Impact of dipeptidyl-peptidase 4 inhibitors on cardiovascular diseases. [electronic resource] - Vascular pharmacology 10 2018 - 17-26 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

1879-3649

10.1016/j.vph.2018.05.010 doi


Animals
Blood Glucose--drug effects
Cardiovascular Diseases--blood
Cardiovascular System--drug effects
Diabetes Mellitus, Type 2--blood
Dipeptidyl Peptidase 4--metabolism
Dipeptidyl-Peptidase IV Inhibitors--adverse effects
Humans
Prognosis
Protective Factors
Risk Factors